Table 1 The clinical and MRI characteristics of patients (n = 12)
MR1 scan | Sex | Age | Region | ADC valuc (l0 3 mm2/s) | Pathological and IHC |
|---|---|---|---|---|---|
Patient 1 | F | 26 | Zygoma | 1.12 | spindie shaped tumor cells and scattered in trabecular bone tissue and bone like matrix tissue; Ki-67 (10–20%), CK (−), SMA and CD99 (+) |
Patient 2 | F | 40 | Jaw | 1.56 | a large number of chondrocytes with obvious heteromorphism and bone septum; viaentin (+), S-100 and CK (−), Ki-67(60%) |
Patient 3 | M | 56 | Jaw | 1.54 | A large number of chondrocytes; S-100(−), Viacntin(+), CK(−), Ki-67(50%) |
Patient 4 | M | 85 | Neck | 1.25 | A large number of spindle cells arranged in bundles or vortices, and the cells were slightly deformed, with visible nuclei and mitotic images; viaentin (+), S-100 and CK (−), Ki-67(30%) |
Patient 5 | F | 62 | Jaw | 1.36 | A large number of spindle cells; Ki-67(10–20%), CK(−), SMA (+) |
Patient 6 | F | 59 | Jaw | 1.55 | a large number of chondrocytes with obvious heteromorphism and bone septum; viaentin (+), Ki-67(30%) |
Patient 7 | F | 62 | Buccal | 0.56 | Lymphoid hyperplasia; PCK(−), EMA(−), CD20(+), CD79a(+), PAX-5(+), CD3(−), CD38(+), CyclinDI(−), MUMl(−), CD30(−), CD 10(+), Bcl-6(−), Bcl-2(−), CD23(−), CD5(+), Ki67(70%) |
Patient 8 | M | 85 | Tongue | 0.31 | Lymphoid hyperplasia, destroyed lymphoid follicles structure; CD3T(+), BCL-6(−), BCL-2(+), CD 10(−), cyclinDl(−), CD79a(+), Pan-5(+), kappa(−), Ki-67(< 10%) |
Patient 9 | M | 56 | Parotid gland | 0.37 | Lymphoid hyperplasia with obvious heteromorphism; CD3(+), CD20(+), BCL-2(+), BCL-6(+), CD 10(+), Muml(+), PAX-5(+), CD79a(+), Ki-67(70 -80%) |
Patient 10 | M | 67 | Parotid gland | 0.54 | Lymphoid hyperplasia, tumor cells infiltrated glands in some areas, serous acini and adipose tissue display; CD20(+), CD 10 (+), CD3 partial cells (+), CD21 showed FDC network, BCL-6 (+), BCL-2 (+), CD38 germinal center positive (+) |
Patient 11 | M | 13 | Parotid gland | 0.57 | Lymphoid hyperplasia, CD3T(+), CD10(−), BCL-6(+), BCL-2(+), CD79a(+), Ki-67(40–50%) |
Patient 12 | M | 40 | Buccal | 0.61 | Lymphoid hyperplasia, CD3T(+), CD20(−), CD10(−), BCL-6(+), BCL-2(+), CD3 partial cells (+), Ki-67(20%) |